After the Supreme Court overturned Roe in 2022, anti-abortion advocates launched a barrage of litigation, including a federal suit in Texas aimed at mifepristone, one drug in a two-drug regimen used in medication abortions.

U.S. District Judge Matthew Kacsmaryk ruled that Missouri, Kansas and Idaho can move ahead with a lawsuit seeking to revamp prescribing and use of the drug. Kaczmaryk, of the Northern District of Texas, has a history of strong antiabortion views, according to The Washington Post .

A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill mifepristone nationwide.

Since the U.S. Supreme Court’s decision in 2022 to allow states to regulate abortion access, support for expanded access to abortion pills has significantly increased, including among those living in states with abortion bans,